IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Bayer Sees Slow Growth; Targets Higher Pharma Rank

9:15 AM MST | March 2, 2012 | —Natasha Alperowicz in Leverkusen

Bayer says its fourth-quarter and full-year 2011 results, announced on February 28, were a success despite a challenging economic environment. The company also provided guidance for 2012, saying that it expects sales to increase by about 3% with “slight improvements in Ebitda before special items and core earnings per share.” Dekkers: Good pharma pipeline. Thomas: Chinese growth slowed. Bayer’s fourth-quarter net income reached €397 million ($534.1 million), compared with a loss of €145 million in the year-earlier period. Sales were...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa